CD274 and sarcoma: Sarcoma, LUSC, colorectal adenocarcinoma, and invasive breast carcinoma exhibited PD‐L1 AMP rates of over 15%, while LUAD exhibited rates of 10%‐15%.29 Thus, the rates of PD‐L1 AMP among Chinese patients with LUAD, breast cancer, and CRC were lower than those observed in this previous study.